Moreover, patients who received the BNT162b2 vaccine and have dMMR colon cancer had higher levels of CRP and sedimentation and lower levels of lymphocyte/CRP ratio, which suggest an inflammatory and immune relationship between mRNA-based vaccine and dMMR status. This evidence concerns the gene CRP and malignant colon neoplasm.